Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ENDOMETRIAL NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02725489
What this trial is testing

Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers

Who this might be right for
Breast CancerOvarian CancerFallopian Tube Cancer+4 more
Mary Crowley Medical Research Center 13
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Large-scale testing (Phase 3)UnknownNCT04792749
What this trial is testing

Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer

Who this might be right for
Endometrial Cancer Stage I
Samsung Medical Center 77
Testing effectiveness (Phase 2)WithdrawnNCT01244438
What this trial is testing

Study of FP-1039 in Subjects With Endometrial Cancers

Who this might be right for
Endometrial Cancers With FGFR2 Mutations
Five Prime Therapeutics, Inc.
Early research (Phase 1)Ended earlyNCT05069935
What this trial is testing

FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Fate Therapeutics 16
Not applicableStudy completedNCT01262040
What this trial is testing

Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+5 more
Memorial Sloan Kettering Cancer Center 154
Not applicableLooking for participantsNCT07557225
What this trial is testing

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Urothelial Carcinoma (UC)Colorectal Cancer+11 more
Peking University First Hospital 200
Not applicableActive Not RecruitingNCT04763915
What this trial is testing

Improving Care After Inherited Cancer Testing

Who this might be right for
Inherited Cancer SyndromeProstate CancerColorectal Cancer+2 more
Vanderbilt-Ingram Cancer Center 720
Early research (Phase 1)Study completedNCT03456908
What this trial is testing

F-18 TFB-PET Studies in Cancer Patients Undergoing NIS-containing Viral Therapies

Who this might be right for
Myeloma Before MV-NIS TreatmentEndometrial Cancer Before VSV-hINF-NIS Treatment
Mayo Clinic 2
Not applicableStudy completedNCT03935282
What this trial is testing

Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors

Who this might be right for
Breast NeoplasmProstatic NeoplasmColorectal Neoplasms+3 more
Wake Forest University Health Sciences 645
Not applicableLooking for participantsNCT07595224
What this trial is testing

Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer

Who this might be right for
Endometrial CancerCervix Cancer
Siriraj Hospital 120
Early research (Phase 1)Study completedNCT00315861
What this trial is testing

Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer+1 more
SCRI Development Innovations, LLC 15
Early research (Phase 1)Active Not RecruitingNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Testing effectiveness (Phase 2)Study completedNCT03192059
What this trial is testing

Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer

Who this might be right for
Cervical CancerEndometrial CancerUterine Cancer
University Hospital, Ghent 43
Not applicableStudy completedNCT02093546
What this trial is testing

Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290

Who this might be right for
Recurrent Endometrial Carcinoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT05682950
What this trial is testing

Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmEndometrial Neoplasms
Peking Union Medical College Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT07108270
What this trial is testing

Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC)

Who this might be right for
Neoplasms, Endometrial
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Not applicableUnknownNCT03366051
What this trial is testing

Sentinel Node Mapping in High Risk Endometrial Cancer

Who this might be right for
Endometrial CancerLymph Node Metastases
AC Camargo Cancer Center 178
Early research (Phase 1)Ended earlyNCT06714617
What this trial is testing

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

Who this might be right for
Breast Cancer Stage IIIHER2-positive Metastatic Breast CancerUnresectable Breast Carcinoma+11 more
SystImmune Inc. 3
Next Page